Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 7/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.50 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MRE11 | P49959 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21224715 | 0.93 | HDAC6 (0.63) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224560 | 0.93 | HDAC6 (0.63) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224178 | 0.88 | HDAC6 (0.70) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224180 | 0.88 | HDAC6 (0.70) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| Trifluoroacetic Acid SCHEMBL21224199 | 0.88 | HDAC6 (0.57) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| Trifluoroacetic Acid SCHEMBL21224201 | 0.88 | HDAC6 (0.57) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224494 | 0.85 | HDAC6 (0.67) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224492 | 0.85 | HDAC6 (0.67) | HDAC6MAPTHDAC1HDAC3HDAC4 | |
| SCHEMBL21224198 | 0.84 | HDAC6 (0.66) | HDAC6MAPTHDAC1ELOVL1MEN1 | |
| SCHEMBL21224196 | 0.84 | HDAC6 (0.66) | HDAC6MAPTHDAC1ELOVL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138480-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-04 | — | — | US | disclosed |
| US-20210038611-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138480-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | HDAC6 86/4885MAPT 2074/4885HDAC1 242/4885 |
| US-20210038611-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | HDAC6 86/4885MAPT 2074/4885HDAC1 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.